U.S. markets close in 2 hours 45 minutes
  • S&P 500

    3,628.37
    -7.04 (-0.19%)
     
  • Dow 30

    29,886.31
    -159.93 (-0.53%)
     
  • Nasdaq

    12,084.55
    +47.77 (+0.40%)
     
  • Russell 2000

    1,844.16
    -9.37 (-0.51%)
     
  • Crude Oil

    45.99
    +1.08 (+2.40%)
     
  • Gold

    1,806.90
    +2.30 (+0.13%)
     
  • Silver

    23.37
    +0.07 (+0.30%)
     
  • EUR/USD

    1.1922
    +0.0026 (+0.21%)
     
  • 10-Yr Bond

    0.8670
    -0.0150 (-1.70%)
     
  • GBP/USD

    1.3382
    +0.0023 (+0.17%)
     
  • USD/JPY

    104.3480
    -0.1320 (-0.13%)
     
  • BTC-USD

    19,085.74
    +44.91 (+0.24%)
     
  • CMC Crypto 200

    378.32
    +7.81 (+2.11%)
     
  • FTSE 100

    6,391.09
    -41.08 (-0.64%)
     
  • Nikkei 225

    26,296.86
    +131.27 (+0.50%)
     

Top Ranked Momentum Stocks to Buy for December 3rd

Zacks Equity Research

Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, December 3rd:

Coherus BioSciences, Inc. (CHRS): This commercial-stage biotherapeutics company has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 52.8% over the last 60 days.

Coherus BioSciences, Inc. Price and Consensus

Coherus BioSciences, Inc. Price and Consensus
Coherus BioSciences, Inc. Price and Consensus

Coherus BioSciences, Inc. price-consensus-chart | Coherus BioSciences, Inc. Quote

Coherus BioSciences’ shares gained 7.6% over the last one month above the S&P 500’s increase 1.2%. The company possesses a Momentum Score of A.

Coherus BioSciences, Inc. Price

Coherus BioSciences, Inc. Price
Coherus BioSciences, Inc. Price

Coherus BioSciences, Inc. price | Coherus BioSciences, Inc. Quote

Ironwood Pharmaceuticals, Inc. (IRWD): This commercial biotechnology company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing more than 100% over the last 60 days.

Ironwood Pharmaceuticals, Inc. Price and Consensus

Ironwood Pharmaceuticals, Inc. Price and Consensus
Ironwood Pharmaceuticals, Inc. Price and Consensus

Ironwood Pharmaceuticals, Inc. price-consensus-chart | Ironwood Pharmaceuticals, Inc. Quote

Ironwood Pharmaceuticals’ shares gained 8.2% over the last one month. The company possesses a Momentum Score of A.

Ironwood Pharmaceuticals, Inc. Price

Ironwood Pharmaceuticals, Inc. Price
Ironwood Pharmaceuticals, Inc. Price

Ironwood Pharmaceuticals, Inc. price | Ironwood Pharmaceuticals, Inc. Quote

Otonomy, Inc. (OTIC): This biopharmaceutical company that focuses on development of therapeutics for neurotology has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 9.4% over the last 60 days.

Otonomy, Inc. Price and Consensus

Otonomy, Inc. Price and Consensus
Otonomy, Inc. Price and Consensus

Otonomy, Inc. price-consensus-chart | Otonomy, Inc. Quote

Otonomy’s shares gained 5.9% over the last one month. The company possesses a Momentum Score of A.

Otonomy, Inc. Price

Otonomy, Inc. Price
Otonomy, Inc. Price

Otonomy, Inc. price | Otonomy, Inc. Quote

Unique Fabricating, Inc. (UFAB): This company that engineers and manufactures multi-material foam, rubber, and plastic components has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 4.4% over the last 60 days.

Unique Fabricating, Inc. Price and Consensus

Unique Fabricating, Inc. Price and Consensus
Unique Fabricating, Inc. Price and Consensus

Unique Fabricating, Inc. price-consensus-chart | Unique Fabricating, Inc. Quote

Unique Fabricating’s shares gained 44.2% over the last one month. The company possesses a Momentum Score of B.

Unique Fabricating, Inc. Price

Unique Fabricating, Inc. Price
Unique Fabricating, Inc. Price

Unique Fabricating, Inc. price | Unique Fabricating, Inc. Quote

See the full list of top ranked stocks here

Learn more about the Momentum score and how it is calculated here.

7 Best Stocks for the Next 30 Days

Just released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers “Most Likely for Early Price Pops.”

Since 1988, the full list has beaten the market more than 2X over with an average gain of +24.6% per year. So be sure to give these hand-picked 7 your immediate attention.

See 7 handpicked stocks now >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Unique Fabricating, Inc. (UFAB) : Free Stock Analysis Report
 
Otonomy, Inc. (OTIC) : Free Stock Analysis Report
 
Ironwood Pharmaceuticals, Inc. (IRWD) : Free Stock Analysis Report
 
Coherus BioSciences, Inc. (CHRS) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research